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Abstract  
Background 
Post transplant food allergy (LTFA) is increasingly observed after pediatric liver transplantation (LT). 
Although the immunopathology of LTFA remains unclear, immunoglobulin (Ig) E seems to be 
implicated.  
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Objective 
To study humoral and cellular immunity in pediatric LT patients in search for factors associated with 
LTFA, and compare with healthy controls (HC) and non-transplant food allergic children (FA). 
Methods 
We studied serum Ig levels in 29 LTFA, 43 non-food allergic LT patients (LTnoFA), 21 FA patients 
and 36 HC. Serum specific IgA and IgE against common food allergens in LTFA, IgA1, IgA2 and 
joining-chain containing polymeric IgA (pIgA) were measured. Peripheral blood mononuclear cells 
were analyzed by flow cytometry for B and T cell populations of interest. 
Results 
Serum IgA and specific IgA were higher in LTFA compared to LTnoFA. LTFA patients had the 
highest proportion of circulating T follicular helper cells (cTfh). The percentage of cTfh correlated 
positively with serum IgA. Unique in LTFA was also the significant increase in serum markers of 
mucosal IgA and the decrease in the Th17 subset of CXCR5- CD4+ cells compared to HC. Both LT 
patients exhibited a rise in IgA+ memory B cells and plasmablasts compared to HC and FA.  
 
Conclusions 
LT has an impact on humoral immunity, remarkably in those patients developing FA.  
The increase in serum markers of mucosal IgA, food allergen specific IgA and cTfh cells observed in 
LTFA, point towards a disturbance in intestinal immune homeostasis in this patient group. 
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Abbreviations 
FA; food allergy 
HC; healthy controls 
Ig; immunoglobulin 
J-chain; joining chain 
GC; germinal centers 
LTFA; liver transplant associated food allergy 
LTnoFA; liver transplant patients without food allergy 
PBMC; peripheral blood mononuclear cells 
pIgA; polymeric IgA 
pIgR; polymeric immunoglobulin receptor 
Tfh; T follicular helper cells 
Tfr; T follicular regulatory cells 
Treg; regulatory T cells 
 
Introduction 
Food allergy (FA) is increasingly reported after pediatric liver transplantation (LT) (2-5). The 
underlying pathogenesis remains unresolved. In our experience, liver transplant associated FA 
(LTFA) is seen in 28% of children (6). Young age at time of transplantation and immunosuppression 
with tacrolimus are associated with LTFA (4,6). Immunoglobulin (Ig) E seems implicated in the 
immunopathology as most patients present IgE-mediated signs, positive skin prick testing and/or 
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elevated specific IgE for the responsible food antigen(s) (6). The type of Ig produced by B cells is 
heavily influenced by help from T helper 2 lymphocytes providing cognate costimulatory molecules 
and cytokines for Ig class switching (7). Tacrolimus, a calcineurin antagonist, inhibits nuclear factor 
of activated T cells (NFAT) signalling and T cell activation (8,9). The current knowledge on the 
influence of calcineurin inhibition on humoral immunity remains limited and no data are available on 
serum Ig levels other than IgE in LTFA.  
IgA is thought to play a protective role in the context of FA mainly through the function of mucosal 
IgA. As neutralizing antibody, IgA contributes to mucosal homeostasis by limiting the uptake of 
antigens from the gut, hence preventing primary sensitisation or triggering of allergic reactions by 
food antigens (1). Eighty percent of the body’s plasma cells are found in the gut mucosa, the largest 
effector organ of humoral immunity. In the small intestine, these are primarily IgA-producing cells 
(80%). In humans, serum IgA is predominantly IgA1, while mucosal IgA includes a substantial 
fraction of IgA2 (1, 10). Most mucosal plasma cells produce dimers and larger polymers of IgA 
containing joining (‘J’)-chain. The ‘J-chain’ facilitates binding of polymeric IgA (pIgA) to the 
polymeric immunoglobulin receptor (pIgR). This receptor exports pIgA across the epithelial layer into 
the intestinal lumen (1). At the apical membrane of the epithelial cell the proteolytic fragment 
‘secretory component’ (SC) is cleaved of the pIgR to release pIgA containing ‘J-chain’ as well as SC 
into the gut (11).  
T follicular helper cells (Tfh), a CD4+ subset which provides help to B cells undergoing isotype 
switching and affinity maturation in germinal centers (GC), play an essential role in the generation of 
high-affinity IgA and maintenance of the mucosal barrier (12). The quality of intestinal IgA critically 
depends on the number and the nature of Tfh in Peyer’s patches (13).  
To investigate the mechanism of LTFA and the potential role of IgA, we measured levels of IgA1, 
IgA2 and ‘J-chain’ containing pIgA as indirect serum markers of mucosal immunity as well as 
specific IgA and IgE against common food antigens. Furthermore, peripheral blood mononuclear cells 
(PBMC) of LTFA patients were analyzed by flow cytometry in comparison with age-matched liver 
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transplant patients without food allergy (LTnoFA) and food allergic patients (FA) and healthy 
controls (HC), focusing on Ig expression in B cells, regulatory T cell (Treg) and circulating Tfh 
phenotypes.    
 
 
Methods 
Study population 
The study population consisted of 4 groups of children (0-16 y): 29 LTFA, 43 LTnoFA, 21 FA 
patients and 36 HC. Demographic data and the indications for LT are shown in table 1. Table E1 
(online repository) summarizes the clinical features, the responsible food allergens and the diagnostic 
parameters in LTFA patients. In the FA group, IgE-mediated and mixed IgE-mediated FA was seen in 
respectively 16 and 5 out of 21 children. Data regarding immunosuppressive treatment in LTFA and 
LTnoFA patients are shown in table E2 (online repository). We also analysed serum Ig in renal 
transplant patients and children with chronic parenchymal (non-immune mediated) liver disease. 
Results are shown in figure E1 (online repository). For flowcytometric analysis of PBMC, we 
equalled out a likely age effect on the cell populations tested by matching each LTFA patient (median 
age 6.92 y; range 2.5-14.9 y) with a peer of the same age (difference < 12 months) in the LTnoFA 
(7.6 y; 2.3-14.9 y) and HC (6.1 y; 2.5-14.2 y) group. In the FA group only 21 age-matched individuals 
could be included (6.1 y; 1.5-13.8 y).  
LTFA and LTnoFA patients were recruited within the departments of pediatric gastroenterology of 
Cliniques Universitaires Saint-Luc (Brussels, Belgium), Hospital Jeanne de Flandre (Lille, France) 
and Ghent University Hospital (Ghent, Belgium). HC consisted of children admitted for minor day 
care surgery (urology, ophthalmology, dental care) under general anaesthesia at Ghent University 
Hospital without any previous history or symptoms of atopy or FA. FA patients were recruited in the 
pediatric gastroenterology clinic of Ghent University Hospital.  
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The diagnosis of FA was confirmed by a pediatric gastroenterologist and based on convincing clinical 
signs followed by a clear response to elimination (disappearance of signs after withdrawing of the 
food allergen from the diet) and provocation (re-occurrence of signs when food antigen is 
reintroduced in diet). Supervised (mostly open) food challenge was performed when clinical history 
and clinical features were not unequivocal. Only patients with typical IgE-mediated (signs within 
minutes to hours of ingestion of foods) or mixed IgE-mediated (signs with delayed/subacute onset in 
the presence of positive skin prick testing and/or serum specific IgE) were included in the study. Skin 
prick testing (prick to prick) was performed with fresh products according to standard guidelines (14). 
Histamine chloride and sodium chloride (0.9 %) were used as positive and negative controls, 
respectively. Specific IgE was measured by the ImmunoCAP assay (Phadia®). Informed consent was 
obtained from the parents and/or patients. An extensive doctor’s questionnaire was taken from the 
parents to obtain detailed information regarding medical antecedents, family history, diet history and 
history of atopic signs (in case of LT patients, both prior to and post-transplant). Additional clinical 
data and the results of the diagnostic tests were collected from the medical records. Exclusion criteria 
were: recent (<3 months before visit) history of infection or acute cellular rejection, recent treatment 
with high dose steroids, recent immunisations or a previous history of (non-allergic) immune 
mediated diseases. In the LTnoFA and HC groups, patients with asthma, allergic rhinitis or atopic 
dermatitis were also excluded. The study was approved by the ethics committee of Ghent University 
Hospital, the Cliniques Universitaires Saint-Luc and Hospital Jeanne de Flandre.  
Serum immunoglobulin levels 
Total serum IgA, IgE, IgG, and IgM concentrations were determined by nephelometry (Behring 
Nephelometer Analyzer II). Serum specific IgA and IgE levels against a mix of the most frequently 
encountered food allergens in LTFA, containing egg white, cow’s milk, fish, wheat, peanut and 
soybean (fx5 CAP, Phadia), were measured by the UNICAP system (Phadia, Thermo Fisher 
Scientific, Sweden). IgA1 and IgA2 were measured by ELISA in serum (human IgA1 and IgA2 ELISA 
Southern Biotech). All according to the manufacturers’ guidelines. Human reference serum (Bethyl, 
TX) containing known amounts of IgA1 and IgA2 was used as standard. 
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Western blot for ‘J-chain’ containing pIgA 
Serum samples (dilution, 1:50) were heated at 100°C for 5 minutes, loaded in a SDS-12% PAGE gel 
and run at 100V for 15 minutes, then at 180V for 45 minutes. Proteins were transferred onto 
nitrocellulose membrane (Thermo Fisher, Waltham, USA) at 0.18A for 2 hours at RT. The membrane 
was blocked with 5% BSA (Sigma-Aldrich, Saint-Louis, USA) in TBS with 0.1% Tween 20 (Sigma-
Aldrich, Saint-Louis, USA) for 1 hour at RT, washed and incubated with anti-human J-chain rabbit 
Ab (made in house) overnight at 4°C. Membranes were then incubated for 1 hour at RT with 
secondary anti-rabbit immunoglobulin G (IgG)-HRP linked (Cell signaling, Danvers, USA). 
Immunoreactive bands were revealed by chemiluminescence (GE Healthcare, Pittsburgh, USA) and 
detected by Chemidoc XRS apparatus (Bio-rad, Hercules, USA). Quantification was made by 
Quantity One software (Bio-rad, Hercules, USA). Results were expressed in arbitrary units, as 
corrected for a standard of purified human J-chain, and then as a ratio on total IgA levels.  
Flow cytometry 
PBMC were freshly isolated by ficoll-hypaque density gradient and cryopreserved at -150°C for 
collective analysis. Thawed PBMC were stained with fixable viability dye 506 (eBioscience) and 
fluorescently labelled monoclonal antibodies using manufacturers’ instructions. Following 
monoclonal antibodies were used: CD138-FITC, CD3 PerCP-Cy5.5, CD123-PE, CD56-PE-Cy5, 
CD8-PE-Cy7, BDCA1-Alexa Fluor 647, HLA-DR-Alexa Fluor 700, CD19-APC-Cy7, CD11c-Pac 
Blue, CD20 –PerCP-Cy5.5, IgE-PE, CD278-FITC (ICOS), CD45RO PE-Cy5, CCR6-PECy7, CD25-
APC-Cy7, CD4-Pac Blue (all from Biolegend); CD38-PE-Cy7, CD274-PE (PD-L1), Foxp3-APC (all 
from eBioscience); IgG-FITC, IgM-PE-Cy5, IgD-Brilliant Violet 605, CXCR3-Brilliant Violet 605, 
CD27-PE-TxRed, CXCR5-Biotin, Streptavidin-PE CF594 (all from BD); CD14-PE-TxRed (Caltag); 
IgA-APC (Miltenyi). The cells were acquired on a BD LSR Fortessa and the data analyzed with 
FlowJo software.   
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Statistics 
Data were analysed in Prism 6 for Mac OS X. Z-scores were calculated for serum Ig values to correct 
for age-dependent reference ranges. Kruskall-Wallis test was used to compare groups (p<0.05 
statistically significant) followed by Mann-Whitney U test to compare groups mutually and 
Bonferroni post test for multiple comparisons (p<0.008 statistically significant). To compare the flow 
cytometric data between the age-matched subjects Wilcoxon-matched-pairs signed rank test was used 
with Bonferroni post test (p<0.008 statistically significant). For correlation analysis Spearman’s test 
was used (p<0.05 statistically significant). 
 
Results 
Serum IgA, food allergen specific IgA and IgE and serum markers for mucosal IgA are 
increased in LTFA. 
Serum IgA levels were specifically increased in those patients diagnosed with de novo food allergy 
(LTFA) compared to those without food allergy (LTnoFA) (p=0.003) and healthy controls (HC) 
(p=0.002) whilst serum IgA did not differ significantly between LTnoFA, HC and food allergic 
children (FA). Serum IgE was, as expected, higher in LTFA and FA patients (p<0.001). No difference 
was found in distribution of serum IgG and IgM across groups (fig. 1). Furthermore, serum food 
allergen specific IgA was raised in LTFA compared to HC (p<0.001), LTnoFA (p=0.02) and FA 
(p=0.04). Understandably, LTFA and FA patients had significantly higher specific IgE levels than 
LTnoFA and HC (all p<0.001) (fig. 2).  
Since IgA was increased in LTFA, we looked at serum markers of mucosal IgA. We found that the 
ratio of serum IgA2 and J-chain containing pIgA on total IgA were higher in LTFA compared to HC 
(p=0.002; p=0.003) (fig. 2). 
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IgA+ memory B cells and IgA+ plasmablasts are increased at the expense of their IgM+ 
counterparts in liver transplant patients.  
To check whether elevated serum IgA levels resulted from an increase in IgA producing B cells, we 
collected and stained PBMC to evaluate the surface Ig expression of CD19+ B cells. We looked at the 
surface expression of IgA, IgE, IgG and IgM on CD27+ memory B cells and CD38+ plasmablasts. The 
percentage of IgA+ memory B cells was significantly higher in the total group of liver transplant 
patients (LT) compared to HC (both p<0.001) and FA (p<0.001; p=0.004). We found a concomitant 
decrease in percentage of IgM+ memory B cells in LT compared to HC (p<0.001) and in LTFA 
patients compared to FA (p=0.004), suggesting an increase in IgM to IgA class switching. The 
percentage of IgA+ plasmablasts was also higher in LT than HC (p<0.001) and in LTFA than FA 
patients (p=0.002) and was equally reflected by a decrease in IgM+ plasmablasts in LT compared to 
HC (p<0.001) and LTFA compared to FA (p=0.005) (fig. 3). No difference was seen in IgG+ and IgE+ 
memory B cells and plasmablasts between the groups. 
CD45RO+ CD4+ memory T cells are increased in liver transplant patients. 
Because B cell differentiation and class switching is a process heavily influenced by helper T cells, 
we also studied T helper cell populations in the peripheral blood of age-matched patients and healthy 
controls. No difference was seen in percentage of CD4+ T cells within alive T lymphocytes between 
the groups. CD45RO+ CD4+ memory cells however were significantly higher in the total LT group 
than in HC and FA (p<0.001). Reciprocally, the percentage of naive CD45RO- CD4+ cells was 
decreased in LT patients compared to HC and FA (p<0.001) (fig. 4).  
LTFA patients have the highest proportion of CD45RO+ CXCR5+ cells within the CD4+ T cell 
compartment. 
Within the CD45RO+ T cell compartment, we looked at CXCR5+ circulating Tfh (cTfh) and CXCR5- 
non-follicular T helper cells and their Th1 (CXCR3+ CCR6-), Th2 (CXCR3- CCR6-) and Th17 
(CXCR3- CCR6+) subsets. We found an increase in cTfh in all LT patients compared to HC and FA 
(p<0.001).  Within the LT group, cTfh were higher in LTFA than in LTnoFA patients (p=0.03). Also 
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more non-follicular memory T helper cells were found in LT patients compared to HC (p<0.001; 
p=0.006) but these cells were not different between LTFA and LTnoFA (fig. 4). Furthermore, within 
cTfh, all LT had a decrease in Th1 (p<0.001) in favour of Th2 cells (p=0.007) compared to HC, 
which was not observed in the non-follicular T helper cells. Th17 cells, on the contrary, were 
decreased in the non-follicular memory T cells in LTFA compared to HC (p=0.003) but not in cTfh 
(fig. 5).  
Natural and induced regulatory CD4+ T cells are decreased in liver transplant patients.  
Treg play an important role in the induction and maintenance of tolerance for food allergens. We 
therefore looked at CD25+ foxp3+ Treg within the naive CD45RO- and memory CD45RO+ CXCR5+ 
and CXCR5- T cells. Natural (CD45RO-) and induced CD45RO+ CXCR5- Treg and T follicular 
regulatory cells (Tfr) were decreased in all LT patients compared to HC. All p-values are shown in 
figure 6.  
Serum IgA levels correlate positively with cTfh frequency.                                                                                           
We analyzed the correlation between IgA Z-scores and the percentage of Tfh cells in all subjects. A 
significant positive correlation was found between both variables (r=0.4027; p<0.0001) (fig. 7). No 
correlation was found between percentage of Tfh cells and IgE, IgM and IgG Z-scores. Furthermore, 
no correlation was found between IgA Z-scores and IgE Z-scores, serum food allergen specific IgA 
and percentage of IgA2. The serum IgA Z-scores correlated positively with the frequencies of CD27
+
 
and CD38+ IgA+ B cells (r= 0.3, p=0.002; r=0.2, p=0.03 respectively).  
 
Of note, we also compared CD8+ T cells, CD14+ monocytes, CD138+ plasma cells, CD3- CD14- 
CD56+ NK cells, CD3- CD14- CD19- CD56- HLA DR+ cD11c+ myeloid and CD123+ plasmacytoid 
dendritic cells. In these subsets we did not find any differences between the 4 groups.  
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Discussion 
We investigated humoral and cellular immunity in pediatric LT patients with and without FA 
compared to HC and FA patients in search for factors that could be associated with LTFA. 
When comparing LTFA with LTnoFA patients, serum IgA and food allergen specific IgA levels as 
well as serum IgE and food allergen specific IgE levels are higher in the LTFA group with LTFA 
patients having a higher proportion of cTfh than LTnoFA patients. Unique in LTFA is also the 
significant increase in serum markers of mucosal IgA and the decrease in the Th17 subset of CXCR5- 
CD4+ cells compared to HC. Both LTFA and LTnoFA patients exhibited a rise in IgA+ memory B 
cells and plasmablasts, CXCR5+ circulating Tfh (15) and CXCR5- non-follicular CD4+ cells and a 
decrease in the Treg compartment compared to HC and FA. The decrease in Treg cells likely puts LT 
patients more at risk to develop FA. Furthermore, the percentage of cTfh, which is highest in LTFA 
patients, correlates positively with serum IgA.  
The rise in serum IgA in LTFA seems to be in conflict with the protective role of IgA in FA (1) and in 
allergy in general (16,17) since selective IgA deficiency is associated with an increased prevalence of 
atopy and FA (18). 
An increase in serum IgA could result from defective intestinal IgA secretion with back leaking of 
IgA into the circulation or from increased IgA production. The latter may ensue from induction of 
IgA class switching or stimulation of the longevity and/or Ig production in plasma cells. 
The increased proportions of serum IgA2 and ‘J-chain’ containing pIgA, observed in LTFA, could fit 
with defective secretory IgA defense. Frossard et al. showed in a mouse model of FA that serum IgA 
was strongly increased in anaphylactic mice. Sensitized mice exhibited increased β-lactoglobulin-
specific IgA levels in serum but not in feces, in contrast to tolerant mice who had increased levels in 
feces but not in serum (19). A disturbed integrity of the gut membrane or impaired transepithelial 
transport of IgA can lead to a deficiency in secretory IgA and a subsequent rise in serum IgA. In 
analogy with our findings, pIgR deficient knock-out mice present a remarkable increase in 
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preferentially dimeric serum IgA (20). These mice have a strong predisposition for anaphylaxis, lack 
secretory IgA and exhibit aberrant mucosal leakiness with increased uptake of food proteins and 
commensal bacteria (21).  Treatment with tacrolimus, known to be associated with LTFA (2,6,22), 
increases intestinal permeability (23, 24) and might hence affect secretory immunity.  
We found an increase in IgA+, with a concomitant decrease in IgM+, memory B cells and plasmablasts 
in LT patients (without any difference in surface IgG+ and IgE+), which might be suggestive of IgM to 
IgA class switching. Furthermore, the proportion of blood cTfh is increased in LT and is highest in 
LTFA patients. These cells share functional properties with Tfh from secondary lymphoid organs as 
they can induce naive and memory B cells to become Ig producing cells (15). cTfh can be further 
subdivided in three subsets: cTfh1 (CXCR3+ CCR6-), cTfh2 (CXCR3- CCR6-) and cTfh17 (CXCR3- 
CCR6+) cells (25). LT patients were found to have a shift towards the cTfh2 subset with a decrease in 
the cTfh1 subset, leaving the percentage of cTfh17 cells unaltered. Within the CXCR5+ compartment 
CXCR5+ foxp3+ CD25+ T follicular regulatory cells (Tfr) tune the GC responses by limiting the 
number and the quality of Tfh cells and selection of the GC B cells, thereby preventing unwanted 
production of autoantibodies and autoimmune destruction (26-28). We found a decrease in circulating 
Tfr in LT patients, which can contribute to an increase in cTfh and IgA producing GC B cells. We 
indeed found a positive correlation between serum IgA and the percentage of cTfh and not for the 
other serum Ig. This observation is indicative for a T cell dependent, rather than innate, IgA induction, 
taking place in GC.  
Besides the increase in cTfh, also CXCR5- CD4+ cells were increased in LT patients. Within this 
compartment Th1 and Th2 cells were not different from HC but Th17 cells were decreased in LTFA 
compared to HC. Th17 cells have been implicated in a number of autoimmune diseases but their role 
in IgE-mediated allergic disorders remains unclear. One study is available investigating Th17 
responses in human FA providing the first evidence of a systemic impairment in Th17 responses in 
FA children (29). A reduced proportion of IL-17 producing CD4+ T cells and an impaired IL-17 
response in CD4+ T cells in PBMC stimulated in vitro with both peanut and control antigens was seen 
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in peanut allergic children. The impairment in Th17 response was unique to FA and not seen in atopic 
patients without FA.  
Treg play a primary role in controlling adaptive immune responses and maintaining tolerance to self-
antigens and harmless non–self-antigens, including food-borne antigens (30). Several studies suggest 
deficiencies in allergen-specific Treg in allergic diseases (31-35). Both natural and induced CD4+ 
CD25+ foxp3+ Treg were found to be decreased in all LT compared to HC.  
The changes observed in LTFA are not encountered in FA patients, which is indicative that LTFA 
patients represent a unique population.  
The strength of this study lies in the investigation of a considerably large, well-defined group of 
pediatric LTFA patients. In the LTnoFA and HC groups, we excluded patients with asthma, allergic 
rhinitis or atopic dermatitis. In the LTFA and FA groups, asthma and allergic rhinitis did not occur, 
however, respectively 9 and 6 children also suffered from atopic dermatitis. Therefore, the observed 
differences might not be ascribed to FA only, the presence of atopic dermatitis in the same patients 
might also play a role.  Because of the retrospective nature of this study, any observed difference 
might be either cause or consequence of LTFA. However the results presented here are a solid basis 
for future prospective studies on the pathogenesis and risk factors for LTFA. Since LTFA 
significantly affects the daily life of a substantial proportion of pediatric LT patients, there is a need to 
review our current immunosuppressive regimens and consider more ‘Treg friendly’ drugs such as 
rapamycin, an mTOR inhibitor, which has been shown to facilitate the development and survival of 
Treg (36, 37).   
In conclusion, LT has an impact on humoral immunity. Serum IgA is significantly increased in LTFA. 
The exact mechanism and the precise link with LTFA needs to be further elucidated. The increase in 
serum markers of mucosal IgA, food allergen specific IgA and circulating Tfh cells point towards a 
disturbance in intestinal immune homeostasis. 
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Table 1: demographic features and indication for liver transplantation. 
 
 
LTFA LTnoFA FA HC 
Number (sex) 29 
16 M 
43 
23 M 
21 
16 M 
36 
18 M 
Age at blood test (y)* 6.5 
(1.5-14.9) 
8.79 
(0.9-15.3) 
6.67 
(2.5-15.7) 
5.08 
(0.5-13.7) 
Age at LT (y)* 0.86 
(0-3) 
2.55 
(0-15) 
NA NA 
Time interval LT – diagnosis 
FA (m)* 
9 
(1-155) 
NA NA NA 
Follow-up after LT (y)* 5.7 
(1.6-13.1) 
4.2 
(0.3-15.2) 
NA NA 
Indication LT 
- EHBA 
- ALF 
- PFIC 
- A-1-AT deficiency 
- IEM 
- Alagille syndrome 
- Hepatoblastoma 
- Other causes 
 
21/29 
3/29 
1/29 
- 
1/29 
1/29 
- 
2/29 
 
 
19/43 
6/43 
4/43 
2/43 
5/43 
1/43 
4/43 
2/43 
 
NA 
 
NA 
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(*) median (range);  
A-1-AT, alpha-1-antitrypsin deficiency; ALF, acute liver failure; EHBA, extrahepatic biliary atresia; 
FA, food allergic patients; HC, healthy controls; IEM, inborn errors of metabolism; LT, liver 
transplantation; LTFA, patients with liver transplant associated food allergy; LTnoFA, liver transplant 
patients without food allergy; M, male; m, months; NA, not applicable; PFIC, progressive familial 
intrahepatic cholestasis; y, years 
 
Figure legends  
Figure 1: serum IgA is elevated in LTFA patients. Scatter dot plots (with mean and standard error 
of the mean) of Z-scores for serum immunoglobulin A (A), IgE (B), IgG (C) and IgM (D) in patients 
with liver transplant associated food allergy (LTFA), liver transplant patients without food allergy 
(LTnoFA), food allergic patients (FA) and healthy controls (HC). Mann-Whitney U test was used to 
compare groups mutually with Bonferroni post test. * p=0.003; ** p=0.002; *** p=0.02; **** 
p<0.001. 
 
Figure 2: food allergen specific IgA and the proportions of IgA2 and J-chain containing 
polymeric IgA on total IgA are elevated in LTFA sera. Scatter dot plots (with mean and standard 
error of the mean) of specific IgA (A) and IgE (B) serum concentrations against a panel of food 
allergens (egg white, cow’s milk, fish, wheat, peanut and soybean) and of the percentage of serum 
IgA2 (C) and serum joining-chain (J-chain) containing polymeric IgA (pIgA) (D) of total IgA 
concentration in patients with liver transplant associated food allergy (LTFA), liver transplant patients 
without food allergy (LTnoFA), food allergic patients (FA) and healthy controls (HC). Mann-Whitney 
U test was used to compare groups mutually with Bonferroni post test. * p<0.001; ** p=0.02; *** 
p=0.04; **** p=0.002; ° p=0.003. 
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Figure 3: increased frequency of IgA+ B cells and decreased frequency of IgM+ B cells in liver 
transplant patients. PBMC were gated on alive CD19+ lymphocytes for B cells. Gating strategy for 
CD27+ memory B cells and CD38+ B cells are shown. (A, D). Gating strategies and frequency for 
IgA+ (B, E) and IgM+ (C, F) cells in CD27+ and CD38+ B cell populations in age-matched patients 
with liver transplant associated food allergy (LTFA), liver transplant patients without food allergy 
(LTnoFA), food allergic patients (FA) and healthy controls (HC). Wilcoxon-matched-pairs signed 
rank test was used to compare groups mutually with Bonferroni post test. * p<0.001; ** p=0.004; *** 
p=0.002; **** p=0.005. 
 
Figure 4: increased frequencies of memory CD4+ T cells and T follicular helper cells in LTFA. 
PBMC were gated on alive CD3+CD4+ T cells for T helper cells. Gating strategy (A) and frequencies 
of CD45RO+ (B), CD45RO- (C), CD45RO+ CXCR5+ (D) and CD45RO+ CXCR5- (E) cells of total 
CD4+ T cells in age-matched patients with liver transplant associated food allergy (LTFA), liver 
transplant patients without food allergy (LTnoFA), food allergic patients (FA) and healthy controls 
(HC). Wilcoxon-matched-pairs signed rank test was used to compare groups mutually with 
Bonferroni post test. * p<0.001; ** p=0.03; *** p=0.006. 
 
Figure 5: shift in CD4+ T helper cell subsets in liver transplant patients. PBMC were gated on 
alive CD3+CD4+CD45RO+ T cells as shown in figure 4.  Gating strategies (A, E) and frequencies for 
CXCR3+ CCR6- Th1 (B, F), CXCR3-  CCR6- Th2 (C, G) and CXCR3- CCR6+ Th17 (D, H) subsets 
within CD45RO+ cTfh CXCR5+ and CXCR5-  T cells in age-matched patients with liver transplant 
associated food allergy (LTFA), liver transplant patients without food allergy (LTnoFA), food allergic 
patients (FA) and healthy controls (HC). Wilcoxon-matched-pairs signed rank test was used to 
compare groups mutually with Bonferroni post test. * p<0.001; ** p=0.007; *** p=0.003. 
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Figure 6: decreased regulatory T cells in liver transplant patients. PBMC were gated on alive 
CD3+CD4+ T cells. Flow plots demonstrating gating strategy for CD45RO en CXCR5 (A). Frequency 
of natural Treg (nTreg) (B), induced CXCR5- Treg (iTreg) (C) and T follicular regulatory cells (Tfr) 
(D) in age-matched patients with liver transplant associated food allergy (LTFA), liver transplant 
patients without food allergy (LTnoFA), food allergic patients (FA) and healthy controls (HC). 
Wilcoxon-matched-pairs signed rank test was used to compare groups mutually with Bonferroni post 
test. * p=0.001; ** p=0.003; *** p<0.001; **** p=0.002. 
 
Figure 7: serum IgA levels correlate with frequency of cTfh. IgA Z-score versus the percentage of 
circulating T follicular helper cells (cTfh) of total CD4+ T cells in age-matched patients with liver 
transplant associated food allergy (LTFA), liver transplant patients without food allergy (LTnoFA), 
food allergic patients (FA) and healthy controls (HC). Spearman’s test was used for correlation 
analysis (r=0.4027; p<0.0001). 
 
Figure E1: serum Ig in pediatric renal transplant and chronic liver disease patients in 
comparison with the other study groups. Scatter dot plots (with mean and standard error of the 
mean) of Z-scores for serum immunoglobulin A (A), IgE (B), IgG (C) and IgM (D) in patients with 
liver transplant associated food allergy (LTFA), liver transplant patients without food allergy 
(LTnoFA), food allergic patients (FA), healthy controls (HC), pediatric renal transplant patients (RT) 
and children with chronic parenchymal liver disease (CLD). Mann-Whitney U test was used to 
compare groups mutually with Bonferroni post test. * p<0.001; ** p=0.004; *** p=0.003; **** 
p=0.02; ° p=0.002; °° p=0.007. 
In liver transplant patients transplanted before July 2003, the immunosuppressive protocol consisted 
of a peroperative bolus of 10 mg/kg methylprednisolone, followed by maintenance 
immunosuppression with cyclosporine (target through concentrations 200-250 ng/ml the first 3 
months, 150-200 ng/ml the first year post transplant, < 150 ng/ml afterwards) and prednisolone 
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(dosage of 2 mg/kg during 5 days, progressively tapered and discontinued after 3 months). From July 
2003 on, basiliximab was added as induction immunosuppression (10 mg/20 mg at day 0 and day 4 
post transplant for children < 30 kg/≥ 30 kg), furthermore cyclosporine was replaced by tacrolimus 
(target through concentrations 10-12 ng/ml the first 3 months, 8-10 ng/ml the first year post 
transplant, < 8 ng/ml afterwards). Mycophenolate mofetil was associated to calcineurin inhibitors on 
indication (e.g. renal impairment, recurrent rejection episodes) in a dose of 600 mg/m2 twice daily 
(max. 2 g daily). In the renal transplant program the immunosuppressive protocol has been similar 
with two minor differences. Instead of prednisolone, prednisone 30 mg/m2 is used twice daily tapered 
gradually after one week during the first 3 months with maintenance of low dose prednisone 
afterwards. Furthermore, mycophenolate mofetil is associated in each renal transplant patient. 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
